Hosted by the Biotechnology Innovation Organisation, the event is the largest global event for the biotechnology industry that attracts the leading biotech companies, scientists, research institutions, advisors, and qualified investors, providing extensive networking and partnering platform to support innovation, investment, and value creation.
Raúl Insa, CEO of SOM Biotech highlights: “The BIO International Convention is a key event to meet high profile partners and investors to explore areas of common interest and foster drug development initiatives and innovation. SOM Biotech is achieving outstanding results with its proprietary AI- ligand-based drug discovery platform, which we´d like to share with investors and potential business partners. Our unique technology has enabled us to build a robust drug development pipeline for orphan/CNS drug candidates. The Convention is a great opportunity to engage in strong partnerships with pharma companies and to meet with qualified investors. We look forward to identifying and sharing new business opportunities with both to continue growing.”